ORGANIC
LETTERS
2003
Vol. 5, No. 11
1845-1846
Concise Total Synthesis of
(±)-Maritidine
Claire Bru, Claude Thal, and Catherine Guillou*
Institut de Chimie des Substances Naturelles,
CNRS AVenue de la Terrasse 91198 Gif-sur-YVette, France
Received February 26, 2003
ABSTRACT
Maritidine can be readily obtained from the corresponding protected â,γ-unsaturated ketone. The quaternary carbon of maritidine was created
for the first time via an intramolecular Heck reaction.
Maritidine alkaloids1 have been found to possess cytotoxic
properties (Figure 1).2 These Amaryllidaceae alkaloids
previously created by different approaches involving long
multistep sequences.5 It should be noted that to date it is not
possible to oxidize (()-dihydromaritidine (3) to maritidine
(1) (Figure 1).
In our synthetic pathway, we planned to use for the first
time an intramolecular Heck reaction for the construction
of the quaternary center of the Amaryllidaceae maritidine-
(3) Maritidine: (a) Rao, R. V.; Rao, K.; Seshagiri, J. V. L. N. Curr. Sci.
1979, 48, 110. (b) Tani, S.; Kobayashi, N.; Fujiwara, H.; Shingu, T.; Kato,
A. Chem. Pharm. Bull. 1981, 29, 3381. (c) Hung, S.; Ma, G.; Sung, G.
Huaxue Xuebao 1981, 39, 529. (d) Ghosal, S.; Ashutosh, R.; Razdan, S.
Phytochemistry, 1985, 24, 635. (e) Ma, G.; Li, H. Y.; Lu, C.; Yang, X.;
Hong, S. Heterocycles 1986, 24, 2089. (f) Ghosal, S.; Singh, S.; Srivastava,
R. S. Phytochemistry 1986, 25, 1975. (g) Kihara, M.; Koike, T.; Imakura,
Y.; Kia, K.; Shingu, T.; Kobayashi, S. Chem. Pharm. Bull. 1987, 35, 1070.
(h) Bastida, J.; Llabres, J. M.; Viladomat, F.; Codina, C.; Rubiralta, M.;
Feliz, M. Planta Med. 1988, 54, 524. See also refs 2a,b. Oxomaritidine: (i)
Herrera, M. R.; Brun, R.; Villadoma, F.; Codina, C.; Bastida, J. Planta
Med. 2001, 67, 191.
(4) Maritidine: (a) Schwartz, M. A.; Holton, R. A. J. Am. Chem. Soc.
1970, 92, 1090. (b) Kametani, T.; Kohno, T.; Shibuya, S.; Fukumoto, K.
Chem. Commun. 1971, 14, 775. (c) Kametani, T.; Kohno, T.; Shibuya, S.;
Fukumoto, K. Tetrahedron 1971, 27, 5441. (d) Yamada, S.; Tomioka, K.;
Koga, K. Tetrahedron Lett. 1976, 1, 57. (e) Tomioka, K.; Shimizu, K.;
Yamada, S.; Koga, K. Heterocycles 1977, 6, 1752. (f) Tomioka, K.; Koga,
K.; Yamada, S. Chem. Pharm. Bull. 1977, 25, 2681. (g) Kita, Y.; Takada,
T.; Gyoten, M.; Tohma, H.; Zenk, M. H.; Eichhorn, J. J. Org. Chem. 1996,
61, 5857. Oxomaritidine: (h) Kotani, E.; Takeuchi, N.; Tobinaga, S. J. Chem.
Soc., Chem. Commun. 1973, 550. (i) Kotani, E.; Takeuchi, N.; Tobinaga,
S. Tetrahedron Lett. 1973, 29, 2735. (j) Ley, S. T.; Schucht, O.; Thomas,
A. W.; Murray, P. J. J. Chem. Soc., Perkin Trans. 1 1999, 1251. See also
ref 5a.
Figure 1.
display a spiro quaternary carbon. The incorporation of this
quaternary center is the critical element in the total synthesis
of maritidine-type alkaloids. Because of their limited avail-
ability from natural sources,3 several syntheses of these
compounds have been reported employing a biomimetic
intramolecular phenolic oxidative cyclization as the crucial
step in the formation of the tetracyclic framework.4 However,
the quaternary carbon of dihydromaritidine (3) has been
(1) For reviews, see: (a) Hoshino, O. In The Alkaloids; Cordell, G. A.,
Ed.; Academic Press: New York, 1998; Vol. 51, p 362. (b) Martin, S. F.
In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1987; Vol.
30, p 251.
(2) (a) Alarcon, M.; Cea, G.; Weigert, G. EnViron. Contam. Toxicol.
1986, 37, 508. (b) Pacheco, P.; Silva, M.; Steglich, W.; Watson, W. H.
ReV. Latinoam. Quim. 1978, 9, 28.
(5) (a) Wijnberg, J. B. P. A.; Speckamp, W. N. Tetrahedron 1978, 34,
2579. (b) Keck, G. E.; Webb, R. R. J. Org. Chem. 1982, 47, 1302. (c)
Michael, J. P.; Howard, A. S.; Katz, R. B.; Zwane, M. I. Tetrahedron Lett.
1992, 33, 6023.
10.1021/ol0343358 CCC: $25.00 © 2003 American Chemical Society
Published on Web 04/29/2003